The respective relationships between lipoprotein profile, Macular pigment optical density, and serum Concentrations of Lutein and Zeaxanthin

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 11, 2010, Pages 5897-5905

  Loane, Edward ^a,b   Nolan, John M ^a,c   Beatty, Stephen ^a,c,d  

^a Ireland   (Ireland)

^b ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

^c The Institutes of Vision Research   (Ireland)

^d Whitfield Clinic   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; DIET RESTRICTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIFESTYLE; MACULAR PIGMENT; MALE; NORMAL HUMAN; OPTICAL DENSITY; PHOTOMETRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FOOD HABITS; HUMANS; LUTEIN; MALE; MIDDLE AGED; PHOTOMETRY; QUESTIONNAIRES; RETINAL PIGMENTS; TRIGLYCERIDES; XANTHOPHYLLS; YOUNG ADULT;

EID: 79952486009     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4878     Document Type: Article

References (44)

1. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci. 1993;34(6):2033-2040.
2. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll- free monkeys. Invest Ophthalmol Vis Sci. 2005;46(2): 692-702.
3. Loane E, Kelliher C, Beatty S, Nolan JM. The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br J Ophthalmol. 2008;92(9):1163-1168.
4. Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004;291(15):1900-1901.
5. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290(15): 2057-2060.
6. Klein R, Wang Q, Klein BEK, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual-acuity. Invest Ophthalmol Vis Sci. 1995;36(1):182-191.
7. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr. 1995;62(6):S1448-S1461.
8. Erdman JW, Jr., Bierer TL, Gugger ET. Absorption and transport of carotenoids. Ann N Y Acad Sci. 1993;691:76-85.
9. Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols oxygenated and hydrocarbon carotenoids: Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17(4):786-796.
10. Clevidence BA, Bieri JG. Association of carotenoids with human plasma lipoproteins. Methods Enzymol. 1993;214:33-46.
11. Connor WE, Duell PB, Kean R, Wang Y. The prime role of HDL to transport lutein into the retina: evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporter. Invest Ophthalmol Vis Sci. 2007;48(9):4226-4231.
12. Wang W, Connor SL, Johnson EJ, Klein ML, Hughes S, Connor WE. Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am J Clin Nutr. 2007;85(3):762-769.
13. Cardinault N, Abalain JH, Sairafi B, et al. Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients. Clin Chim Acta. 2005;357(1): 34-42.
14. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem. 2004;279(47): 49447-49454.
15. Bhosale P, Li B, Sharifzadeh M, et al. Purification and partial characterization of a lutein-binding protein from human retina. Biochemistry. 2009;48(22):4798-4807.
16. Willett WC. Future-directions in the development of food-frequency questionnaires. Am J Clin Nutr. 1994;59(1):S171-S174.
17. Bodner CH, Soutar A, New SA, et al. Validation of a food frequency questionnaire for use in a Scottish population: correlation of antioxidant vitamin intakes with biochemical measures. J Hum Nutr Diet. 1998;11(5):373-380.
18. Masson LF, McNeill G, Tomany JO, et al. Statistical approaches for assessing the relative validity of a food-frequency questionnaire: use of correlation coefficients and the kappa statistic. Public Health Nutr. 2003;6(3):313-321.
19. O'Connell ED, Nolan JM, Stack J, et al. Diet and risk factors for age-related maculopathy. Am J Clin Nutr. 2008;87(3):712-722.
20. Nolan JM, Stack J, Mellerio J, Godhinio M, O'Donovan O, Beatty S. Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res. 2006; 31(2):199-213.
21. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT. McCance and Widdowson's The Composition of Foods. Fifth revised and extended edition. London: Royal Society of Chemistry; 1991.
22. O'Neill ME, Carroll Y, Corridan B, et al. A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br J Nutr. 2001;85(4):499-507.
23. United States Department of Agriculture. USDA-NCC Carotenoid Database for U.S. Foods. Ref Type: Data File; Washington DC: USDA; 1998.
24. Foods Standards Agency. McCance and Widdowson's The Composition of Foods. Sixth summary Edition. Cambridge: Royal Society of Chemistry; 2002.
25. Rand WM, Windham CT, Wyse BW, Young VR. Compiling Data for Food Composition Databases. New York: United Nations University Press; 1991.
26. Bone RA, Landrum JT, Cains A. Optical density spectra of the macular pigment in vivo and in vitro. Vision Res. 1992;32(1):105-110.
27. Wooten BR, Hammond BR, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci. 1999;40(11):2481-2489.
28. Kirby ML, Galea M, Loane E, Stack J, Beatty S, Nolan JM. Foveal anatomic associations with the secondary peak and the slope of the macular pigment spatial profile. Invest Ophthalmol Vis Sci. 2009;50:1383-1391.
29. Nolan JM, Stringham JM, Beatty S, Snodderly DM. Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci. 2008;49(5):2134-2142.
30. Loane E, Stack J, Beatty S, Nolan JM. Measurement of macular pigment optical density using two different heterochromatic flicker photometers. Curr Eye Res. 2007;32(6):555-564.
31. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3(2):213-219.
32. Morrison A, Hokanson JE. The independent relationship between triglycerides and coronary heart disease. Vasc Health Risk Manag. 2009;5(1):89-95.
33. Dejager S, Bruckert E, Chapman MJ. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res. 1993;34(2):295-308.
34. Delcourt C, Michel F, Colvez A, et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol. 2001;8(4):237-249.
35. Klein R, Klein BEK, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of agerelated maculopathy: The Beaver Dam Eye Study. Ophthalmology. 2003;110(4):636-643.
36. Rizzo M, Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. Q J Med. 2006;99(1):1-14.
37. Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol. 1999;6:125-143.
38. Klein R, Deng Y, Klein BE, et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol. 2007;143(3):473-483.
39. Gale CR, Hall NF, Phillips DIW, Martyn CN. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003;44(6):2461-2465.
40. Nolan JM, Stack J, O'Donovan O, Loane E, Beatty S. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res. 2007;84(1):61-74.
41. Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999;22(4):336-345.
42. Beatty S, Nolan J, Kavanagh H, O'Donovan O. Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys. 2004;430(1):70-76.
43. Loane E, McKay GJ, Nolan JM, Beatty S. Apolipoprotein E genotype is associated with macular pigment optical density. Invest Ophthalmol Vis Sci In press. 2010;51(5)2636-2643.
44. Vishwanathan R, Goodrow-Kotyla EF, Wooten BR, Wilson TA, Nicolosi RJ. Consumption of 2 and 4 egg yolks/d for 5 wk increases macular pigment concentrations in older adults with low macular pigment taking cholesterol-lowering statins. Am J Clin Nutr. 2009; 90(5):1272-1279.